Submit an IND/CTA filing for one of the pipeline programs
Delivered by the deadline
Under re-examination This entry has been challenged and is being re-checked against the sources.
- Announced
- 1 Feb 2021
- Due
- 31 Dec 2021
- Delivered
- by 1 Jan 2021
- Deadline
- Met
- Late
- Not met
- Today
What the company said
“Submit an IND/CTA filing for one of the five above-named programs in 2021”
What we found
Evidence strength A What the grades mean
The company submitted and received approval for a CTA filing for TSHA-118 in 2021, and also submitted a CTA filing for TSHA-102 in November 2021.
-
A Taysha Gene Therapies, Inc. 10-K filed 2022-03-31
“For Rett syndrome, we submitted a CTA filing in November 2021” ✓ confirmed on the page
-
A Taysha Gene Therapies, Inc. 10-Q filed 2022-08-11
“We submitted a CTA filing for TSHA-118 which was approved by Health Canada in 2021” ✓ confirmed on the page
Checked 25 Oct 2026.
Commitment DNA
The structured record of this commitment. Fields the company did not state are left blank rather than guessed.
- Event type
- Regulatory filing
- Indicative materiality
- Medium rules
- Action
- Submit
- Deliverable
- IND/CTA filing
- In the company’s control
- Medium
- Specificity
- Medium
- Depends on
- Regulatory
How this entry was checked
- Commitment recordedThe company's words were matched word for word against the filing.
- First checkAn AI model, Gemini (Google), read the company's later filings and recorded the outcome with a quoted passage.
- Second check: agreesA different AI model, Claude (Anthropic), re-read the evidence without being told the outcome and reached the same answer.
Confirmed. This outcome counts towards the company's Kept Score. How verification works
Are you Taysha Gene Therapies, Inc.? You can publish an official statement next to this entry, free. Add a statement.
Is something here wrong or out of date? Companies and readers can ask us to check it. Please bring a link to a public source.
Report an error in this entry Reference: KI-C-2021-TSHA-022708 · Corrections policy